Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: A multicenter, exploratory analysis

European Journal of Surgical Oncology

Volumn 39, Issue 4, 2013, Pages 386-395

  Silva, M F ^a,b,c   Sapisochin, G ^d   Strasser, S I ^e   Hewa Geeganage, S ^e   Chen, J ^f   Wigg, A J ^f   Jones, R ^g   Saraiva, R ^h   Kikuchi, L ^h   Carrilho, F ^h   Fontes, P R O ^b,c   Charco, R ^d  

^a FLINDERS UNIVERSITY   (Australia)

^b Santa Casa   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f FLINDERS MEDICAL CENTRE   (Australia)

^g AUSTIN HOSPITAL   (Australia)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hepatocellular carcinoma; Liver resection; Liver transplantation

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; SORAFENIB;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CHEMOEMBOLIZATION; CHILD TURCOTTE PUGH SCORE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REOPERATION; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BRAZIL; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS;

EID: 84875222199     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.12.011     Document Type: Article

References (40)

1. D.M. Parkin The global health burden of infection-associated cancer in the year 2002 Int J Cancer 118 2006 3030 3044
2. M. Sherman Epidemiology of hepatocellular carcinoma Oncology 78 Suppl. 1 2010 7 10
3. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
4. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 120 1022
5. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference J Hepatol 35 2001 421 430
6. T.M. Pawlik Debate: resection for early hepatocellular carcinoma J Gastrointest Surg 13 2009 1026 1028
7. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
8. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
9. H.A. Edmonson, and P.E. Steiner Primary carcinoma of the liver: study of 100 cases among 48000 necropsies Cancer 7 1954 462 503
10. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix Design and endpoints of clinical trial in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
11. J. Vauthey, G. Lauwers, and N. Esnaola Simplified staging for hepatocellular carcinoma J Clin Oncol 20 2002 1527 1536
12. A. Chiappa, A.P. Zbar, R.A. Audisio, B.E. Leone, F. Biella, and C. Staudacher Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma Eur J Surg Oncol 26 2000 387 392
13. G.L. Grazi, G. Ercolani, and F. Pierangeli Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value Ann Surg 234 2001 71 78
14. J. Yamamoto, S. Okada, and K. Shimada Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection Hepatology 34 2001 707 713
15. R.T.P. Poon, S.T. Fan, and C.M. Lo Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236 2002 602 611
16. G. Ercolani, G.L. Grazi, and M. Ravaioli Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 2003 536 543
17. A. Ferrero, L. Viganò, and R. Polastri Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients World J Surg 29 2005 1101 1105
18. C.C. Wu, S.B. Cheng, W.M. Ho, J.T. Chen, T.J. Liu, and F.K. P'eng Liver resection for hepatocellular carcinoma in patients with cirrhosis Br J Surg 92 2005 348 355
19. C. Margarit, A. Escartín, L. Castells, V. Vargas, E. Allende, and I. Bilbao Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation Liver Transpl 10 2005 1242 1251
20. L. Capussotti, A. Ferrero, L. Viganò, A. Muratore, R. Polastri, and H. Bouzari Portal hypertension: contraindication to liver surgery? World J Surg 30 2006 992 999
21. K. Taura, I. Ikai, and E. Hatano Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 239 patients Surgery 142 2007 685 694
22. T. Ishizawa, K. Hasegawa, and T. Aoki Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
23. Y.K. Park, B.W. Kim, H.J. Wang, and M.W. Kim Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class A patients with cirrhosis Transplant Proc 41 2009 1691 1697
24. R. Santambrogio, E. Opocher, and M. Zuin Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class A liver cirrhosis Ann Surg Oncol 16 2009 3289 3298
25. J. Zhou, Z. Wang, and S.J. Qiu Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation J Cancer Res Clin Oncol 136 2010 1453 1460
26. G. Sapisochin, I. Bilbao, and J. Balsells Optimizing of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series World J Surg 34 2010 2146 2154
27. M. Abdel-Wahab, T.S. El-Husseiny, E.E. Hanafy, M.E. Shobary, and E. Hamdy Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver Langenbecks Arch Surg 395 2010 625 632
28. K.K. Lee, D.G. Kim, I.S. Moon, M.D. Lee, and J.H. Park Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma J Surg Oncol 101 2010 47 53
29. Z.Y. Huang, G. Chen, X.Y. Hao, R.Y. Cai, Y.F. Zhao, and X.P. Chen Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors Langenbecks Arch Surg 396 2011 193 199
30. Sapisochin G, Castells L, Dopazo C, et al. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol, in press.
31. V. Mazzaferro Results of liver transplantation: with or without Milan criteria? Liver Transpl 13 11 Suppl. 2 2007 S44 S47
32. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
33. G. Germani, K. Gurusamy, and M. Garcovich Which matters most: number of tumors, size of the largest tumor, or total tumor volume? Liver Transpl 17 Suppl. 2 2011 S58 S66
34. J. Bruix, A. Castells, and J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroentrology 111 1996 1018 1022
35. Centre for Evidence-based Medicine (Oxford, UK). Accessed on April 2012. Available from: http://www.cebm.net.
36. Weels GA, Shea B, O'Connel D, et al. The Newcasttle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Accessed on April 2012. Available from: http://ohri.ca/programs/clinical-epidemiology/ oxford.asp.
37. G.H. Guyatt, A.D. Oxman, and G. Vist Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
38. H.C. Sun, L.X. Qin, and L. Wang Risk factors for postoperative complications after liver resection Hepatobiliary Pancreat Dis Int 4 2005 370 374
39. S. Tremosini, M. Reig, C.R. De Lope, A. Forner, and J. Bruix Treatment of early hepatocellular carcinoma: towards personalized therapy Dig Liver Dis 42 Suppl. 2010 S242 S248
40. E. Boleslawski, G. Petrovai, and S. Truant Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis Br J Surg 99 2012 855 863